The Application of Art Therapy to Patients Undergoing Hemodialysis Treatment

NCT ID: NCT07005960

Last Updated: 2025-09-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

70 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-06-16

Study Completion Date

2026-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Purpose of the Study: This study aims to investigate the effect of art therapy on anxiety and psychological resilience levels in Chronic kidney disease(CKD) patients undergoing hemodialysis patients.

Hemodialysis patients undergo long-term treatment, often experiencing psychological issues such as anxiety and depression, which significantly reduce their quality of life. Among non-pharmacological approaches to alleviate these symptoms, art therapy has gained increasing attention. Art therapy helps patients shift their focus away from their illness, fosters self-confidence, reduces anxiety, and promotes relaxation .

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Preliminary Implementation of the Study Implementation of the Research During the data collection phase of the study, the researcher will explain the purpose of the study to patients who meet the inclusion criteria, provide necessary information, and obtain both verbal and written informed consent. After the information and consent process, all data in the "Personal Information Form" related to the patient will be filled out by the researcher.

Patients will be divided into two groups: the experimental group (35 participants) and the control group (35 participants). Patients in the experimental group will be administered the Volunteer Information and Consent Form, the Patient Information Form, the Brief Resilience Scale, and the State-Trait Anxiety Inventory prior to the intervention.

Then, for four weeks, the experimental group will participate in art therapy sessions involving drawing and painting for approximately 30 minutes, twice a week. In the first week, patients will be asked to paint a given picture. In the second week, they will be given a different picture to paint. In the third week, they will be asked to draw and paint a picture of their choice. In the fourth week, they will again be asked to draw and paint a picture of their choice. At the end of the fourth week, the scales will be completed again. By this point, each patient will have painted four given pictures and drawn and painted four of their own.

After this, there will be a one-month break from art therapy, during which no intervention will be conducted. At the end of this month, the same scales will be administered again to the experimental group.

For the control group (35 participants), during the first week, without any intervention beyond standard clinical procedures, participants will complete the Volunteer Information and Consent Form, the Patient Information Form, the Brief Resilience Scale, and the State-Trait Anxiety Inventory. This process will be repeated in the fourth week. One month later, the same scales will be administered again without any intervention.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anxiety Psychological Well-Being Hemodialysis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Two groups, experimental group and control group
Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

DOUBLE

Participants Outcome Assessors
A total of 35 participants each for the experimental and for control groups will be randomly selected

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Art therapy experimental group

Patients in the experimental group will be administered the Volunteer Information and Consent Form, the Patient Information Form, the Brief Resilience Scale, and the State-Trait Anxiety Inventory prior to the intervention.

Group Type ACTIVE_COMPARATOR

Art Therapy for Anxiety in Hemodialysis Patients

Intervention Type OTHER

Patients in the experimental group will be administered the Volunteer Information and Consent Form, the Patient Information Form, and the State-Trait Anxiety Inventory prior to the intervention.

Then, for four weeks, the experimental group will participate in art therapy sessions involving drawing and painting for approximately 30 minutes, twice a week. In the first week, patients will be asked to paint a given picture. In the second week, they will be given a different picture to paint. In the third week, they will be asked to draw and paint a picture of their choice. In the fourth week, they will again be asked to draw and paint a picture of their choice. At the end of the fourth week, the scales will be completed again.

After this, there will be a one-month break from art therapy, during which no intervention will be conducted. At the end of this month, the same scales will be administered again to the experimental group.

Art Therapy for Resilience in Hemodialysis Patients

Intervention Type OTHER

Patients in the experimental group will be administered the Volunteer Information and Consent Form, the Patient Information Form, the Brief Resilience Scale, prior to the intervention.

Then, for four weeks, the experimental group will participate in art therapy sessions involving drawing and painting for approximately 30 minutes, twice a week. In the first week, patients will be asked to paint a given picture. In the second week, they will be given a different picture to paint. In the third week, they will be asked to draw and paint a picture of their choice. In the fourth week, they will again be asked to draw and paint a picture of their choice. At the end of the fourth week, the scales will be completed again.

After this, there will be a one-month break from art therapy, during which no intervention will be conducted. At the end of this month, the same scales will be administered again to the experimental group.

Art therapy control group

For the control group (35 participants), during the first week, without any intervention beyond standard clinical procedures, participants will complete the Volunteer Information and Consent Form, the Patient Information Form, the Brief Resilience Scale, and the State-Trait Anxiety Inventory. This process will be repeated in the fourth week. One month later, the same scales will be administered again without any intervention.

Group Type ACTIVE_COMPARATOR

Art Therapy for Anxiety in Hemodialysis Patients

Intervention Type OTHER

Patients in the experimental group will be administered the Volunteer Information and Consent Form, the Patient Information Form, and the State-Trait Anxiety Inventory prior to the intervention.

Then, for four weeks, the experimental group will participate in art therapy sessions involving drawing and painting for approximately 30 minutes, twice a week. In the first week, patients will be asked to paint a given picture. In the second week, they will be given a different picture to paint. In the third week, they will be asked to draw and paint a picture of their choice. In the fourth week, they will again be asked to draw and paint a picture of their choice. At the end of the fourth week, the scales will be completed again.

After this, there will be a one-month break from art therapy, during which no intervention will be conducted. At the end of this month, the same scales will be administered again to the experimental group.

Art Therapy for Resilience in Hemodialysis Patients

Intervention Type OTHER

Patients in the experimental group will be administered the Volunteer Information and Consent Form, the Patient Information Form, the Brief Resilience Scale, prior to the intervention.

Then, for four weeks, the experimental group will participate in art therapy sessions involving drawing and painting for approximately 30 minutes, twice a week. In the first week, patients will be asked to paint a given picture. In the second week, they will be given a different picture to paint. In the third week, they will be asked to draw and paint a picture of their choice. In the fourth week, they will again be asked to draw and paint a picture of their choice. At the end of the fourth week, the scales will be completed again.

After this, there will be a one-month break from art therapy, during which no intervention will be conducted. At the end of this month, the same scales will be administered again to the experimental group.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Art Therapy for Anxiety in Hemodialysis Patients

Patients in the experimental group will be administered the Volunteer Information and Consent Form, the Patient Information Form, and the State-Trait Anxiety Inventory prior to the intervention.

Then, for four weeks, the experimental group will participate in art therapy sessions involving drawing and painting for approximately 30 minutes, twice a week. In the first week, patients will be asked to paint a given picture. In the second week, they will be given a different picture to paint. In the third week, they will be asked to draw and paint a picture of their choice. In the fourth week, they will again be asked to draw and paint a picture of their choice. At the end of the fourth week, the scales will be completed again.

After this, there will be a one-month break from art therapy, during which no intervention will be conducted. At the end of this month, the same scales will be administered again to the experimental group.

Intervention Type OTHER

Art Therapy for Resilience in Hemodialysis Patients

Patients in the experimental group will be administered the Volunteer Information and Consent Form, the Patient Information Form, the Brief Resilience Scale, prior to the intervention.

Then, for four weeks, the experimental group will participate in art therapy sessions involving drawing and painting for approximately 30 minutes, twice a week. In the first week, patients will be asked to paint a given picture. In the second week, they will be given a different picture to paint. In the third week, they will be asked to draw and paint a picture of their choice. In the fourth week, they will again be asked to draw and paint a picture of their choice. At the end of the fourth week, the scales will be completed again.

After this, there will be a one-month break from art therapy, during which no intervention will be conducted. At the end of this month, the same scales will be administered again to the experimental group.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Undergoing hemodialysis for at least 6 months,

Willing to participate in the study,

Aged between 18 and 65 years,

No communication disorders,

No infectious diseases.

Exclusion Criteria

Sensory impairments (vision or hearing loss),

Not willing to participate in the study,

Having an infectious disease.

Independent and Dependent Variables:

Independent Variable: Art therapy. Dependent Variables: Scores from the Brief Resilience Scale and State-Trait Anxiety Inventory (STAI 1-STAI 2).

Control Variables: Participants' sociodemographic characteristics.

\-
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

EMİNE İNAL

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

EMİNE İNAL

Principal İnvestigator

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sibel Olca POLAT

Role: STUDY_DIRECTOR

sibelolca@aydın.edu.tr

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Çeşme Alper Çizgenakat State Hospital

Izmir, , Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

EMİNE İNAL

Role: CONTACT

+905445730613

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Berkay Head Nurse

Role: primary

05394836340

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CAU-LEAE-HEM-Eİ-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.